105 related articles for article (PubMed ID: 24369256)
1. [Association of serum decoy receptor 3 protein level with the clinicopathologic features of bladder transitional cell carcinoma].
Wang D; Wang J; Chen G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1831-2. PubMed ID: 24369256
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma.
Zhou J; Song S; Li D; He S; Zhang B; Wang Z; Zhu X
World J Surg Oncol; 2014 Mar; 12():52. PubMed ID: 24597666
[TBL] [Abstract][Full Text] [Related]
3. Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients.
Chen MH; Kan HT; Liu CY; Yu WK; Lee SS; Wang JH; Hsieh SL
J Formos Med Assoc; 2017 Jan; 116(1):49-56. PubMed ID: 26911723
[TBL] [Abstract][Full Text] [Related]
4. Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients.
Yang M; Chen G; Dang Y; Luo D
Ups J Med Sci; 2010 Nov; 115(4):232-7. PubMed ID: 20977315
[TBL] [Abstract][Full Text] [Related]
5. Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children.
Kamal A; Abdelmegeid AK; Gabr MAM; Basanti CWS
Immunol Res; 2021 Dec; 69(6):568-575. PubMed ID: 34383195
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder.
Guan KP; Ye HY; Yan Z; Wang Y; Hou SK
Urology; 2003 Apr; 61(4):719-23. PubMed ID: 12670552
[TBL] [Abstract][Full Text] [Related]
8. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
Xiu Z; Shen H; Tian Y; Xia L; Lu J
Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
[TBL] [Abstract][Full Text] [Related]
9. Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.
Maruyama H; Hirayama K; Nagai M; Ebihara I; Shimohata H; Kobayashi M
Clin Rheumatol; 2016 Oct; 35(10):2469-76. PubMed ID: 27251675
[TBL] [Abstract][Full Text] [Related]
10. DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors.
Edfeldt K; Daskalakis K; Bäcklin C; Norlén O; Tiensuu Janson E; Westin G; Hellman P; Stålberg P
Neuroendocrinology; 2017; 105(2):170-181. PubMed ID: 27829249
[TBL] [Abstract][Full Text] [Related]
11. Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure.
Lin S; Wu B; Lin Y; Wang M; Zhu Y; Jiang J; Zhang L; Lin J
Biomed Res Int; 2019; 2019():9145736. PubMed ID: 31317042
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder.
Ben Bahria-Sediki I; Chebil M; Sampaio C; Martel-Frachet V; Cherif M; Zermani R; Rammeh S; Ben Ammar Gaaied A; Bettaieb A
Urol Int; 2018; 100(4):476-484. PubMed ID: 29719304
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
15. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis.
Kim S; Mi L; Zhang L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):312-7. PubMed ID: 22647538
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.
Lee CS; Hu CY; Tsai HF; Wu CS; Hsieh SL; Liu LC; Hsu PN
Clin Exp Immunol; 2008 Mar; 151(3):383-90. PubMed ID: 18190609
[TBL] [Abstract][Full Text] [Related]
17. Serum decoy receptor 3, a potential new biomarker for sepsis.
Hou YQ; Xu P; Zhang M; Han D; Peng L; Liang DY; Yang S; Zhang Z; Hong J; Lou XL; Zhang L; Kim S
Clin Chim Acta; 2012 Apr; 413(7-8):744-8. PubMed ID: 22280900
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of decoy receptor 3 are associated with disease severity in patients with hemorrhagic fever with renal syndrome.
Dong Y; Shi D; Li M; Dai P; Wang X; Xie M
Intern Emerg Med; 2015 Aug; 10(5):567-73. PubMed ID: 25647584
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 expression during the menstrual cycle and pregnancy, and regulation by sex steroids in endometrial cells in vitro.
Chen HF; Chen JS; Shun CT; Tsai YF; Ho HN
Hum Reprod; 2009 Jun; 24(6):1350-8. PubMed ID: 19246462
[TBL] [Abstract][Full Text] [Related]
20. Gynecomastia and ectopic human chorionic gonadotropin production by transitional cell carcinoma of the bladder.
Nishiyama T; Washiyama K; Tanikawa T; Mineyama H; Sasagawa T; Susuki H; Kitamura Y; Sato S
Urol Int; 1992; 48(4):463-5. PubMed ID: 1413316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
